The drug 'IRS 19'. Instructions for use

The drug "IRS 19" (instruction, testimonials testify to this) is quite effective for the prevention and treatment of respiratory diseases. In addition, the drug helps to increase specific and nonspecific immunity. The medication is available in the form of a nasal spray.

After spraying, the medicine "IRS 19" turns into a fine aerosol covering the nasal mucosa. This provokes a sufficiently rapid immune response. Provision of specific immune defense is carried out due to the local formation of specific antibodies that prevent the subsidence of the infectious agents on the mucosa.

The drug "IRS 19" instruction for use recommends the prevention and treatment of diseases of the upper respiratory tract and bronchi of chronic and acute course. Such pathologies, in particular, include bronchitis, tracheitis, tonsillitis, pharyngitis, laryngitis, sinusitis, rhinitis. The drug "IRS 19" is prescribed after the transferred viral infections (including influenza) to restore immunity (local). Preparation "IRS 19" instruction for use recommends in preparation for routine operations on ENT organs, as well as after operations.

Dosage

Medication "IRS 19" for children instruction allows for use from three months of age.

The solution is administered intranasally (in the nose). One short press on the atomizer is equal to one dose.

For the prevention of the drug in each nostril is administered one dose twice a day. It is recommended to begin therapy two or three weeks before the expected increase in morbidity.

In the treatment of diseases of the upper respiratory tract and bronchus of acute and chronic course, children under three years of age are prescribed one dose each nostril, twice a day. Before the administration of the solution, the nasal mucosa must be cleaned. Use the spray until the symptoms disappear completely. For patients older than three years, the IRS 19 medication is recommended for use at a dose of two to five times per day in each nostril until the signs of infection are eliminated.

After the transferred viral respiratory diseases and influenza for the restoration of immunity, it is recommended to administer the drug twice a day in each nostril for one dose. The use of the drug continues for two weeks.

Before the planned operations and after them, one dose is administered to each nostril, twice a day, fourteen days a day. To begin therapy follows for seven days prior to prospective intervention.

Among the side effects when using the drug "IRS 19" instructions for use draws attention to diarrhea, abdominal pain, nausea. In rare cases, there is a development of bronchitis, laryngitis, sinusitis, rhinopharyngitis, coughing and bronchial asthma. In some cases, the use of a spray can provoke angioedema, hives, eczematoid and erythema-like reactions. Very rarely in practice, there was an increase in temperature (at the beginning of therapy), erythema nodosum, thrombocytopenic purpura.

The medicine "IRS 19" is contraindicated in hypersensitivity to components, as well as in autoimmune pathologies.

In connection with the lack of reliable information on the likelihood of toxic or teratogenic effects on fetal embryonic development , the drug is not prescribed during pregnancy.

It should be noted that at the beginning of therapy it is possible to develop local reactions in the form of sneezing and intensifying the intensity of discharge from the nose. As practice shows, these phenomena are short-lived and do not require withdrawal of the drug.

Before using the tool, you need to read the annotation.